Literature DB >> 3874276

Ten years experience with paravariceal injection sclerotherapy of esophageal varices in children.

K J Paquet.   

Abstract

Esophageal varices in 59 consecutive children with portal hypertension were treated by paravariceal injection sclerotherapy. Repeated injections were performed using a special rigid instrument under general anesthesia. In children older than 10 a flexible endoscope was used without general anesthesia. Using 0.5% Polidocanol, a fibrous layer protecting varices against the further bleeding was produced in 59 children. Complications during treatment included hemorrhage, esophageal ulceration and stricture, each in two children. 55 children have been followed for 6 months to 10 years after two phases of paravariceal injection following the first phase of treatment. Three rebleeds have occurred in this group. Sclerotherapy was repeated. Thereafter, using a regular endoscopic control every year, no rebleeding occurred. Four children with liver cirrhosis died of liver failure. All other children except four foreign ones could be followed. 51 of them (86%) are alive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874276     DOI: 10.1016/s0022-3468(85)80280-3

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

Review 1.  Management of extrahepatic portal hypertension in children.

Authors:  S Sood; A K Chopra; V R Minocha
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

Review 2.  Portal hypertension in children.

Authors:  Simon C Ling
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

3.  Portal hypertension in north Indian children.

Authors:  N K Arora; R Lodha; S Gulati; A K Gupta; P Mathur; M S Joshi; N Arora; D K Mitra
Journal:  Indian J Pediatr       Date:  1998 Jul-Aug       Impact factor: 1.967

4.  Sclerotherapy in extrahepatic portal venous obstruction.

Authors:  Y K Chawla; J B Dilawari; G N Ramesh; U Kaur; S K Mitra; B N Walia
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

5.  Sclerotherapy in noncirrhotic portal fibrosis.

Authors:  Y K Chawla; J B Dilawari; R K Dhiman; M K Goenka; D K Bhasin; R Kochhar; K Singh; U Kaur
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 6.  Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.

Authors:  Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

7.  Longterm outcome after injection sclerotherapy for oesophageal varices in children with extrahepatic portal hypertension.

Authors:  M D Stringer; E R Howard
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 8.  Treatment of portal hypertension in children.

Authors:  J G Maksoud; M E Gonçalves
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

9.  Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis.

Authors:  W D Warren; J M Henderson; W J Millikan; J T Galambos; F C Bryan
Journal:  Ann Surg       Date:  1988-05       Impact factor: 12.969

10.  Omeprazole heals mucosal ulcers associated with endoscopic injection sclerotherapy.

Authors:  F C Johlin; D R Labrecque; G A Neil
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.